Gemmer Asset Management LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 208 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gemmer Asset Management LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$3,000
-25.0%
28
+21.7%
0.00%
Q4 2021$4,000
+33.3%
230.0%0.00%
Q3 2021$3,0000.0%230.0%0.00%
Q2 2021$3,000
-25.0%
230.0%0.00%
-100.0%
Q1 2021$4,000
+100.0%
230.0%0.00%
Q4 2020$2,0000.0%230.0%0.00%
Q3 2020$2,000
-33.3%
230.0%0.00%
-100.0%
Q2 2020$3,000
+50.0%
230.0%0.00%0.0%
Q1 2020$2,000
-33.3%
23
-8.0%
0.00%0.0%
Q4 2019$3,000
+50.0%
250.0%0.00%
Q3 2019$2,000
-33.3%
250.0%0.00%
-100.0%
Q2 2019$3,000
-57.1%
25
-52.8%
0.00%
-50.0%
Q1 2019$7,0000.0%530.0%0.00%0.0%
Q4 2018$7,000
-53.3%
530.0%0.00%
-60.0%
Q3 2018$15,000
+36.4%
530.0%0.01%
+25.0%
Q2 2018$11,000
+22.2%
530.0%0.00%
+33.3%
Q1 2018$9,000
+28.6%
530.0%0.00%
+50.0%
Q4 2017$7,0000.0%530.0%0.00%
-33.3%
Q3 2017$7,000
+16.7%
530.0%0.00%0.0%
Q2 2017$6,0000.0%53
+1.9%
0.00%0.0%
Q1 2017$6,000
+20.0%
52
+2.0%
0.00%0.0%
Q4 2016$5,0000.0%510.0%0.00%0.0%
Q3 2016$5,000
-16.7%
510.0%0.00%0.0%
Q2 2016$6,000
+20.0%
510.0%0.00%0.0%
Q1 2016$5,000
+150.0%
51
+121.7%
0.00%
+200.0%
Q4 2015$2,0000.0%230.0%0.00%0.0%
Q3 2015$2,000
+100.0%
23
+76.9%
0.00%0.0%
Q2 2015$1,0000.0%13
+30.0%
0.00%0.0%
Q1 2015$1,0000.0%10
-33.3%
0.00%0.0%
Q4 2014$1,0000.0%15
-40.0%
0.00%0.0%
Q3 2014$1,000
-50.0%
25
-13.8%
0.00%0.0%
Q2 2014$2,000
+100.0%
29
+38.1%
0.00%0.0%
Q1 2014$1,000210.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders